Table 1 Sociodemographic and medical characteristics of 143 men with metastatic castration-resistant prostate cancer: frequencies, percentages, mean, standard deviation (SD), min-max
Age (years) | Mean (SD) | 75.0 (7.2) | ||||
Min-max | 50–88 | |||||
Years since primary diagnosis | Mean (SD) | 4.6 (4.7) | ||||
Min-max | 0–22 | |||||
Missing | 0 | |||||
Years since diagnosis of metastatic disease | Mean (SD) | 1.3 (1.9) | ||||
Min-max | 0-13.3 | |||||
Missing | n = 1 | |||||
PSA (ng/ml) | Mean (SD) | 87.8 (219) | ||||
Min-max | 0.50–2082 | |||||
Missing | 0 | |||||
n | % | |||||
Marital status | Married/had a partner | 112 | 78.3 | |||
Single/widowed, | 29 | 20.3 | ||||
Missing | 2 | 1.4 | ||||
Education | Elementary school | 63 | 44.1 | |||
High school | 38 | 26.6 | ||||
University | 41 | 28.7 | ||||
Missing | 1 | 0.7 | ||||
Tumor (T) stage | T1 | 12 | 8.4 | |||
T2 | 29 | 20.3 | ||||
T3 | 70 | 49.0 | ||||
T4 | 21 | 14.7 | ||||
Tx | 6 | 4.2 | ||||
Missing | 5 | 3.5 | ||||
Node (N) stage | N0 | 81 | 56.6 | |||
N1 | 44 | 30.8 | ||||
Nx | 13 | 9.1 | ||||
Missing | 5 | 3.5 | ||||
Metastasis (M) stage | M0 | 76 | 53.1 | |||
M1 | 63 | 44.1 | ||||
Mx | 1 | 0.7 | ||||
Missing | 3 | 2.1 | ||||
Gleason Score | 6 | 13 | 9.1 | |||
7 | 46 | 32.2 | ||||
8 | 35 | 24.5 | ||||
9 | 34 | 23.8 | ||||
10 | 2 | 1.4 | ||||
Missing§ | 13 | 9.1 | ||||
Metastasis site | Bone | 96 | 67.1 | |||
Lymph nodes | 40 | 28.0 | ||||
Lung | 2 | 1.4 | ||||
Liver | 2 | 1.4 | ||||
Other | 1 | 0.7 | ||||
Missing | 2 | 1.4 | ||||
Treatment | Abiraterone | 22 | 15.4 | |||
Docetaxel | 40 | 28.0 | ||||
Enzalutamide | 74 | 51.7 | ||||
Radium-223 | 4 | 2.8 | ||||
Cabazitaxel | 3 | 2.1 | ||||
Analgesic use | Yes/no | 69/74 | 48.3/51.7 |